DCPT1061

DCPT1061 potently inhibits PRMT1, PRMT6 and PRMT8 in vitro with less inhibitory effect on PRMT3, PRMT4, and PRMT5 or other epigenetic enzymes. DCPT1061 has antitumor effect.


Cat. No.: EX-A8387	Purity: >98%

	Chemical structure of DCPT1061

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	585	Inquire
100mg	885	Inquire
250mg	1385	Inquire
1g	get quote
5g	get quote

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	2289726-31-2
Purity	>98%
Formula	C17H20Cl2N2O
Mol Weight	339.259
Color	colorless to light yellow
State	liquid
Solubility	DMSO : ? 250 mg/mL
Shelf Life	>3 years if stored properly
Storage	Pure form -20°C, 3 years ; In solvent -20°C, 1 month
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Jianfeng Wang, et al. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Theranostics. 2021 Mar 12;11(11):5387-5403. [2]. Hongru Tao, et al. PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma. Cancer Res. 2023 Nov 22.
CoA	CoA of DCPT1061

Smiles:	ClC1=CC=CC(OC=2C=CC=CC2CN(C)CCNC)=C1Cl


		Search